Search - tctmd.com

Displaying 521 - 540 of 562

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Presenter: Patrick Tobbia, Bruce R. Brodie, Thomas Stuckey, Brent T. McLaurin, David Cox, Martin Fahy, Ke Xu, Roxana Mehran, Gregg W. Stone

January 03, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Yael L. Maxwell

October 27, 2011

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Daily News

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Caitlin E. Cox

September 28, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

Statin Users Have Better Outcomes After PCI for Stable CAD

L.A. McKeown

July 08, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

Advertisement

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Hope Renewed for Novel Anticoagulant Use in ACS

STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Ticagrelor Gains FDA Approval for Use in ACS

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

Statin Users Have Better Outcomes After PCI for Stable CAD

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content